3,292 Axon Enterprise, Inc $AXON Shares Acquired by CenterBook Partners LP

Key Points

• CenterBook Partners increased its Axon stake by 246.2% in the third quarter, adding 3,292 shares to hold 4,629 shares valued at about $1.96 million.
• Other institutional investors also raised their positions; institutional investors collectively own 79.08% of Axon’s stock.
• Axon’s latest quarter missed analyst expectations, with EPS of $1.72 versus $1.89 expected and revenue of $908.55 million versus $934.33 million expected. Analysts’ consensus rating remains “Moderate Buy,” with a $631.35 average price target.

CenterBook Partners LP lifted its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 246.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,629 shares of the biotechnology company's stock after acquiring an additional 3,292 shares during the quarter. CenterBook Partners LP's holdings in Axon Enterprise were worth $1,956,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in AXON. International Assets Investment Management LLC boosted its holdings in Axon Enterprise by 9,877.5% in the third quarter. International Assets Investment Management LLC now owns 101,172 shares of the biotechnology company's stock valued at $42,747,000 after purchasing an additional 100,158 shares during the last quarter. Calamos Wealth Management LLC grew its position in Axon Enterprise by 1,150.8% during the 3rd quarter. Calamos Wealth Management LLC now owns 14,009 shares of the biotechnology company's stock worth $5,919,000 after purchasing an additional 12,889 shares during the period. Westside Investment Management Inc. grew its position in Axon Enterprise by 330.2% during the 3rd quarter. Westside Investment Management Inc. now owns 2,796 shares of the biotechnology company's stock worth $1,181,000 after purchasing an additional 2,146 shares during the period. Kestra Advisory Services LLC raised its stake in shares of Axon Enterprise by 30,838.4% during the 3rd quarter. Kestra Advisory Services LLC now owns 1,188,963 shares of the biotechnology company's stock valued at $502,361,000 after buying an additional 1,185,120 shares during the last quarter. Finally, Quadcap Wealth Management LLC raised its stake in shares of Axon Enterprise by 3,108.2% during the 3rd quarter. Quadcap Wealth Management LLC now owns 53,833 shares of the biotechnology company's stock valued at $22,746,000 after buying an additional 52,155 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on AXON shares. Zacks Research cut Axon Enterprise from a "strong-buy" rating to a "hold" rating in a report on Tuesday, November 3rd. Raymond James Financial set a $675.00 target price on Axon Enterprise in a report on Thursday, October 15th. Morgan Stanley lifted their price target on Axon Enterprise from $600.00 to $640.00 and gave the company an "overweight" rating in a research report on Thursday, August 6th. TD Cowen reduced their price target on Axon Enterprise from $825.00 to $800.00 and set a "buy" rating for the company in a research report on Monday, October 26th. Finally, Piper Sandler reissued an "overweight" rating and issued a $540.00 price target (down from $561.00) on shares of Axon Enterprise in a report on Friday. Thirteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, Axon Enterprise presently has an average rating of "Moderate Buy" and a consensus target price of $631.35.

Insiders Place Their Bets

In related news, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the transaction, the chief executive officer owned 3,118,012 shares of the company's stock, valued at approximately $1,587,036,927.88. This represents a 0.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the company's stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $480.45, for a total value of $488,617.65. Following the completion of the transaction, the insider directly owned 56,264 shares of the company's stock, valued at $27,032,038.80. The trade was a 1.78% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 37,397 shares of company stock valued at $21,234,034 over the last quarter. Insiders own 4.20% of the company's stock.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q3 revenue reached a record $909 million, up 28% year over year, while software and services revenue rose 43%. Axon also reported AI annual recurring revenue above $100 million, signaling continued demand for its software and AI offerings. Axon Q3 results
• Neutral Sentiment: Axon committed an additional $1.2 billion to drone maker Skydio, bringing its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The move could expand Axon’s Drone as First Responder business, but its scale also raises investment and execution risks. Reuters: Axon invests in Skydio
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of $908.55 million fell short of analyst expectations. Axon’s 2026 revenue forecast was reduced to $3.6 billion from a consensus of about $3.7 billion; its Q4 revenue guidance also came in below estimates. The company cited delays in federal counter-drone projects, while margin pressure added to concerns. Zacks: Q3 miss and outlook
• Negative Sentiment: Several analysts lowered price targets after the results, and Craig Hallum downgraded AXON from Buy to Hold, adding to pressure on investor sentiment. Benzinga: analyst forecast changes
• Negative Sentiment: A class-action lawsuit over Axon’s license-plate surveillance practices is a potential additional legal and reputational overhang. Class-action announcement

Axon Enterprise Price Performance

AXON stock opened at $313.00 on Monday. The firm has a market cap of $25.43 billion, a PE ratio of 100.32, a P/E/G ratio of 5.95 and a beta of 1.48. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.60 and a current ratio of 3.00. The firm's fifty day moving average is $441.53 and its 200 day moving average is $475.20. Axon Enterprise, Inc has a one year low of $307.00 and a one year high of $665.07.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts' consensus estimates of $1.89 by ($0.17). The firm had revenue of $908.55 million during the quarter, compared to analysts' expectations of $934.33 million. Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The firm's quarterly revenue was up 27.8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.17 EPS. On average, research analysts forecast that Axon Enterprise, Inc will post 2.10 EPS for the current year.

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals.

The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Founded in 1993 as TASER International, the company adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into connected devices and software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.